84
57
Growth Score
-8 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
223666
Piramal Pharma Limited develops and manufactures pharmaceuticals, including contract services and consumer healthcare products.
- Vivek Valsaraj: President - Finance and Chief Financial Officer
- Peter DeYoung: CEO, Global PharmaPast Role: Piramal Group, CEO
About the Company
Piramal Pharma Limited develops and manufactures pharmaceutical products, integrating contract development and manufacturing services with branded formulations and consumer healthcare offerings. The company supports drug discovery and development from early-stage research through commercial-scale production for global biopharmaceutical customers.
Its portfolio includes injectable and oral dosage forms, complex generics, over-the-counter remedies, and healthcare products for everyday use. Piramal Pharma Limited operates through specialized business units focused on contract development and manufacturing, complex hospital generics, and consumer products.
